Watch live: House grills FDA commissioner, Abbott executive on baby formula shortage

Watch live: House grills FDA commissioner, Abbott executive on baby formula shortage


[The stream is slated to start at 11 a.m. ET. Please refresh the page if you do not see a player above at that time.]

The head of the Food and Drug Administration and executives from the infant formula industry are set to answer questions from House lawmakers Wednesday about the nationwide shortage that has left parents struggling to find food for their infants.

The House Oversight and Investigations subcommittee hearing will begin at 11 a.m. Lawmakers will question FDA Commissioner Robert Califf, FDA food policy chief Frank Yiannis, and the director of the FDA’s food safety center Susan Mayne during the first portion of the hearing.

The FDA has come under scrutiny from lawmakers for not acting quickly enough to inspect Abbott Nutrition’s infant formula plant in Sturgis, Mich., after a whistleblower warned the agency in October about food safety violations at the plant. The FDA didn’t initiate inspections of the plant until late January, ultimately finding five different strains of Cronobacter – a bacteria that can cause a dangerous blood infection – at the facility.

Four infants who consumed powdered formula from the Abbott plant fell ill and were hospitalized with Cronobacter infections, two of whom died. The FDA, in testimony released ahead of the hearing, said it does not have definitive evidence proving proving the bacteria found at the plant caused the infant illnesses. None of the Cronobacter strains at the Sturgis plant matched two clinical samples from the ill infants, according to the FDA. However, the agency said Cronobacter found at manufacturing plants is considered one of the most likely sources of contaminated infant formula.

Abbott shut down the plant and initiated a voluntary of recall of several products in February, contributing to an infant formula shortage that has left store shelves empty in many parts of the country. Four manufacturers – Abbott, Mead Johnson Nutrition, Nestle USA and Perrigo – control 90% of the domestic infant formula market in the U.S.

House lawmakers will also question Abbott executive Christopher Calamari, Gerber Vice President Scott Fritz, and Reckitt Senior Vice President Robert Cleveland. Nestle owns Gerber and Mead Johnson merged with Reckitt in 2017.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

The niche real estate sector that’s luring big money for small kids’ care
Business

The niche real estate sector that’s luring big money for small kids’ care

A Fortec adaptive reuse project in Barrington, Illinois. Courtesy: Fortec A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to […]

Read More
American Eagle stock jumps 15% as it expects a big holiday, raises forecast after Sydney Sweeney ads
Business

American Eagle stock jumps 15% as it expects a big holiday, raises forecast after Sydney Sweeney ads

An American Eagle advertisement featuring actress Sydney Sweeney on a billboard in Times Square in New York, US, on Thursday, Aug. 7, 2025. Michael Nagle | Bloomberg | Getty Images American Eagle issued bullish holiday guidance and raised its full-year forecast on Tuesday after posting better-than-expected quarterly results.  The apparel company is expecting fiscal fourth […]

Read More
Asset-backed finance is growing fast and drawing new scrutiny
Business

Asset-backed finance is growing fast and drawing new scrutiny

A version of this article appeared in CNBC’s Inside Alts newsletter, a guide to the fast-growing world of alternative investments, from private equity and private credit to hedge funds and venture capital. Sign up to receive future editions, straight to your inbox. The First Brands Group bankruptcy has cast a spotlight on one of the fastest-growing corners […]

Read More